Covington Capital Management’s Core Laboratories CLB Stock Holding History

Covington Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-600	Closed	-$76K	–	694
2018 Q2	$76K	Hold	600	–	–	﹤0.01%	371
2018 Q1	$65K	Hold	600	–	–	﹤0.01%	395
2017 Q4	$66K	Hold	600	–	–	﹤0.01%	419
2017 Q3	$59K	Buy	+600	New	+$58.2K	﹤0.01%	412
2014 Q4	–	Sell	-2,550	Closed	-$373K	–	262
2014 Q3	$373K	Buy	2,550 +705	+38%	+$109K	0.03%	213
2014 Q2	$305K	Buy	+1,845	New	+$328K	0.03%	222

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Covington Capital Management's CLB Position: Q3 2018 in Review

Covington Capital Management sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 600 shares — an estimated $76K sold.

Covington Capital Management first reported a position in CLB in Q2 2014 and held it in 6 quarters. The position peaked at $373K in Q3 2014. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

Covington Capital Management reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
Covington Capital Management sold 600 Core Laboratories shares in Q3 2018, an estimated $76K.
Covington Capital Management first reported a position in Core Laboratories in Q2 2014 and held it in 6 quarters.
Covington Capital Management's Core Laboratories position peaked at $373K in Q3 2014.
359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Covington Capital Management's 13F filing for Q3 2018, filed 15 Nov 2018.